Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $61K 5,000 sh |
| Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 589 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 29.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Maddox Mark DExecutive VP - Administration | Grant or award | A | — 44.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Issa Mohamed KhairieEVP, Head of US Oncology | Tax withholding · 10b5-1 plan | F | $881K 8,264 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Davenport BonnieDirector | Grant or award | A | — 13 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 586 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 5,500 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 23 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Option exercise | M | — 6,145 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 451 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Boone KarenDirector | Option exercise | M | — 280 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Jain CharuDirector | Grant or award | A | $6,033 342 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Foote TimChief Financial Officer | Option exercise | M | — 4,616 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 4,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Warnica Kimberly O.EVP, CLO & Secretary | Grant or award | A | — 44.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Malzahn CraigChief Technology Officer | Grant or award | A | — 35.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 21.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | M | — 37.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Henderson Tracey KExecutive VP Exploration | Grant or award | A | — 44.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Siddiqui Sami A.Chief Financial Officer | Grant or award | A | — 659 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $252K 1,434 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Lehner Keefer McGovernSee Remarks | Disposition to issuer | D | — 10.1K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Matlock RobinDirector | Grant or award | A | $862 10 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Antoine RobertDirector | Grant or award | A | — 26 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Galligan Mary EDirector | Grant or award | A | — 62 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Siddiqui Sami A.Chief Financial Officer | Grant or award | A | — 695 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Siddiqui Sami A.Chief Financial Officer | Grant or award | A | — 23 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Hendricks Dana SChief Financial Officer | Grant or award | A | — 23.7K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Chan MitchellChief Financial Officer | Grant or award | A | — 39.6K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Boone KarenDirector | Option exercise | M | — 280 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 72 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 7,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Siddiqui Sami A.Chief Financial Officer | Grant or award | A | — 23 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lehner Keefer McGovernSee Remarks | Disposition to issuer | D | — 94.3K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $566K 3,251 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 9 | Schaub SydneySVP and Chief Legal Officer | Grant or award | A | — 63.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Peterson Neil W.CHIEF OPERATING OFFICER | Option exercise · 10b5-1 plan | M | $272K 5,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Francis Robert DavidPres Healthcare Pro. Liability | Grant or award | A | — 23.7K sh | Jan 8, 2026 traded Jan 7, 2026 |